The Fort Worth Press - From new treatments to AI: advances in the fight against cancer

USD -
AED 3.672504
AFN 64.500413
ALL 81.998222
AMD 357.803769
ANG 1.790403
AOA 917.999811
ARS 1559.268201
AUD 1.490235
AWG 1.8025
AZN 1.677673
BAM 1.782854
BBD 2.012735
BDT 124.411466
BGN 1.77347
BHD 0.377107
BIF 3003.463993
BMD 1
BND 1.288879
BOB 11.707704
BRL 5.8789
BSD 0.999385
BTN 93.383593
BWP 14.117915
BYN 2.997958
BYR 19600
BZD 2.009818
CAD 1.431185
CDF 2284.999488
CHF 0.84219
CLF 0.025569
CLP 1006.340199
CNY 6.667798
CNH 6.66638
COP 3354.69
CRC 444.296568
CUC 1
CUP 23.984575
CVE 100.51779
CZK 22.209901
DJF 177.949763
DKK 6.798375
DOP 60.418499
DZD 137.054003
EGP 53.737198
ERN 15
ETB 164.020438
EUR 0.90945
FJD 2.286305
FKP 0.76038
GBP 0.759955
GEL 2.590077
GGP 0.76038
GHS 11.732317
GIP 0.76038
GMD 73.498737
GNF 8859.697901
GTQ 7.637401
GYD 209.002981
HKD 7.845035
HNL 26.862474
HRK 6.831965
HTG 131.020966
HUF 335.089756
IDR 18264.85
ILS 3.265055
IMP 0.76038
INR 93.269599
IQD 1514.984389
IRR 1933164.499323
ISK 124.600364
JEP 0.76038
JMD 158.502846
JOD 0.709008
JPY 159.831499
KES 130.050035
KGS 87.449403
KHR 4071.103008
KMF 449.000081
KPW 900.00035
KRW 1329.059689
KWD 0.31167
KYD 0.832836
KZT 444.440393
LAK 22515.053033
LBP 89590.84067
LKR 332.58429
LRD 167.887437
LSL 17.179374
LTL 2.95274
LVL 0.60489
LYD 6.463111
MAD 9.953508
MDL 18.347645
MGA 4544.315048
MKD 55.995815
MMK 2099.801407
MNT 3600.814049
MOP 8.076574
MRU 40.612196
MUR 46.840183
MVR 15.39267
MWK 1732.793079
MXN 18.846835
MYR 4.110597
MZN 63.902977
NAD 17.179061
NGN 1350.2502
NIO 36.77352
NOK 9.68358
NPR 149.412703
NZD 1.81177
OMR 0.384498
PAB 0.999385
PEN 3.411744
PGK 4.495877
PHP 63.661967
PKR 276.292258
PLN 4.01253
PYG 6255.270079
QAR 3.643308
RON 4.863402
RSD 106.986978
RUB 82.003338
RWF 1478.922348
SAR 3.751382
SBD 8.137041
SCR 14.002012
SDG 601.496186
SEK 10.14248
SGD 1.289135
SHP 0.757117
SLE 22.799161
SLL 20969.503664
SOS 571.095199
SRD 37.3845
STD 20697.981008
STN 22.333535
SVC 8.744046
SYP 13002.000337
SZL 17.176326
THB 33.85698
TJS 9.188906
TMT 3.5
TND 3.026701
TOP 2.40776
TRY 50.467602
TTD 6.7815
TWD 32.947897
TZS 2659.998026
UAH 45.116247
UGX 4186.987794
UYU 40.602566
UZS 12002.151381
VES 916.62795
VND 25748
VUV 120.949122
WST 2.823281
XAF 596.560073
XAG 0.022103
XAU 0.000267344295
XCD 2.70255
XCG 1.801044
XDR 0.707052
XOF 596.560073
XPF 108.71765
YER 236.550191
ZAR 17.24949
ZMK 9001.21272
ZMW 20.525699
ZWL 321.999592
SSP 5879.599296
MXV 2.11322
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

From new treatments to AI: advances in the fight against cancer
From new treatments to AI: advances in the fight against cancer / Photo: © AFP/File

From new treatments to AI: advances in the fight against cancer

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology (ESMO), which ends on Tuesday.

Text size:

Here are some of the big announcements made at the five-day conference held in the Spanish city of Barcelona, which brought together 30,000 specialist doctors and researchers from around the world.

- Breastfeeding after cancer -

Women who breastfeed after receiving treatment for breast cancer do not have a higher risk of their cancer returning or of getting new tumours, according to two international studies presented at the conference.

This was also true for women carrying a genetic mutation called BRCA, which significantly increases the chance of developing breast cancer, the research found.

There had previously been concerns about pregnancy and breastfeeding after women had been diagnosed with breast cancer, because both can affect hormone levels.

"These results are key for women who wish to become pregnant and breastfeed their baby after breast cancer," said Fedro Alessandro Peccatori, a researcher and doctor at the European Institute of Oncology in Milan.

- New combination for lung cancer -

Immunotherapy, which stimulates the body's immune system to fight tumours, has already been shown to be an effective weapon against lung cancer.

On Saturday, the results of a phase two trial revealed promising signs against metastatic non-small cell lung cancer, which is when the most common form of lung cancer spreads to other parts of the body.

The trial tested a new combination of two different immunotherapies along with chemotherapy.

"By aiming at a second target of the immune system and combining these treatments, it seems that we are improving response rates -- that is, the number of patients who have their tumours shrink," Nicolas Girard, an oncologist at France's Curie Institute, told AFP.

- Rare pregnancy-linked cancer -

Another combination of immunotherapy and chemotherapy produced excellent results against a very rare form of pregnancy-related cancer which develops in the placenta. The cancer only occurs in around one out of every 10,000 pregnancies.

The combination of treatments led to 96 percent of the cancer in patients being eradicated.

"This is an exceptional result," said Benoit You, a France-based oncologist who presented the research.

- AI for personalised medicine? -

A huge artificial intelligence (AI) algorithm trained on a database of more than a billion images of tumours from around 30,000 patients in the United States also showed promise for future cancer treatment, researchers said Monday.

The model is capable of "detecting a certain number of molecular anomalies and mutations that the human eye is not always able to see," Fabrice Andre, research head at France's Gustave Roussy cancer centre, told AFP.

In the long term, the doctors hope this kind of AI will be able to help them offer personalised treatments for each patient.

- Hope for saving affected organs -

One of the main messages to come out of the ESMO conference was that combining immunotherapy with radiation therapy before surgery improves the overall survival rates for a growing number of cancers, including for the breast, bladder and cervix.

But receiving these kinds of treatments ahead of surgery seems to also allow for the affected organs themselves to be saved, Andre said.

"Organ preservation is absolutely essential to have a quality of life that is as close as possible to normal," he said.

Research presented on Monday showed encouraging results for preserving rectums in patients with cancer affecting this important part of the digestive tract. This only occurs after the treatments have caused the tumour to completely vanish.

"Until now the standard was surgery, but it seems we are entering a new era where surgery could be avoided," said David Sebag- Montefiore, an oncologist and researcher at the UK's University of Leeds.

There are hopes that this treatment combination could also have the potential to work for other cancers, such as those of the ear, nose and throat -- or lungs.

P.Navarro--TFWP